Hiba Narvel, Medical Oncology and Hematology fellow at ASCO, shared a post on LinkedIn:
“Developmental therapeutics poster #2 American Society of Clinical Oncology (ASCO).
It was a distinct honor to represent our team and present our research on Nectin-4 expression dynamics in urothelial cancer.
The best part of the meeting was engaging with so many brilliant minds in precision oncology. We had fantastic discussions on biomarker dynamics, antigen density modulation, and overcoming therapeutic resistance. Bridging multiomics with pragmatic data to optimize patient treatments is exactly where the momentum is heading!
Massive thanks to my incredible mentors Deepak Kilari Razelle Kurzrock, co-authors, and everyone who stopped by to share insights and push the boundaries of developmental therapeutics. Excited to bring this energy back to the clinic!”
Other articles featuring Hiba Narvel on OncoDaily.